Chronic lithium treatment decreases brain phospholipase A2 activity

Neurochemical Research

Volumn 23, Issue 6, 1998, Pages 887-892

  Chang, Michael C J ^a   Jones, Collins R ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Arachidonate; Brain; Lithium; Phoshatidylcholine; Phospholipase A2; Phospholipids

Indexed keywords

ARACHIDONIC ACID; CALCIUM CHELATING AGENT; DIVALENT CATION; FATTY ACID; LITHIUM; LITHIUM CHLORIDE; PHOSPHOLIPASE A2; PHOSPHOLIPID;

ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; FLUOROMETRY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOMETRY; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTIMANIC AGENTS; BRAIN; CHELATING AGENTS; EGTAZIC ACID; ENZYME INHIBITORS; FLUOROMETRY; LITHIUM CHLORIDE; MAGNESIUM CHLORIDE; MALE; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPASES A; RATS; RATS, INBRED F344;

ANIMALIA;

EID: 0031954923     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022415113421     Document Type: Article

References (44)

1. Emilien, G., Maloteaux, J. M., Seghers, A., and Charles, G. 1995. Lithium therapy in the treatment of manic-depressive illness. Present status and future perspectives. A critical review. Arch. Int. Pharmacodyn. 330:251-278.
2. Manji, H. K., Potter, W. Z., and Lenox, R. H. 1995. Signal transduction pathways. Molecular targets for lithium's actions. Arch. Gen. Psychiatry 52:531-543.
3. Mork, A., Geisler, A., and Hollund, P. 1992. Effects of lithium on second messenger systems in the brain. Pharmacpl. Toxicol. 71:4-17.
4. Jope, R. S., and Williams, M. B. 1994. Lithium and signal transduction systems. Biochem. Pharmacol. 47:429-441.
5. Hallcher, L. M., and Sherman, W. R. 1980. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem. 255:10896-10901.
6. Sherman, W. R., Gish, B. G., Honchar, M. P., and Munsell, L. Y. 1989. Effects of lithium on phosphoinositide metabolism in vivo. Fedn. Proc. 45:2639-2646.
7. Horrobin, D. F. 1978. Lithium as a regulator of prostaglandin synthesis. Relevance of manic depressive illness. Pages 243-246, in Johnson, F. N. and Johnson, S., (eds.), Lithium in Medical Practice, University Park Press, Baltimore.
8. Schroder, T., Lempinen, M., Nordling, S., and Kinnunen, P. K. J. 1981. Chlorpromazine treatment of experimental acute fulminant pancreatitis in pigs. Eur. Surg. Res. 13:143-151.
9. Lee, R. E. 1974. The influence of psychotropic drugs on prostaglandin biosynthesis. Prostaglandins 5:63-68.
10. Krupp, P., and Wesp, M. 1975. Inhibition of prostaglandin synthetase by psychotropic drugs. Experientia 31:330-331.
11. 2. Prostaglandins 14:273-281.
12. Bekemeier, H., Giessler, A. J., and Vogel, E. 1977. Influence of MAO-inhibitors, neuroleptics, morphine, mescaline, divascan, aconitine, and pyrogenes on prostaglandin-biosynthesis. Pharmacol. Res. Commun. 9:587-598.
13. Hong, S. L., Carty, T., and Deykin, D. 1980. Tranylcypromine and 15-hydroperoxy-arachidonate affect arachidonic acid release in addition to inhibition of prostaglandin synthesis in calf aortic endothelial cells. J. Biol. Chem. 255:9538-9540.
14. 2 in depression. Prostaglandins Leukotrienes Med. 10:361-367.
15. 2 activities. Biochim. Biophys. Acta 837:288-295.
16. Chang, M. C. J., Grange, E., Rabin, O., Bell, J. M., Allen, D. D., and Rapoport, S. I. 1996. Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci. Lett. 220:171-174.
17. Jones, C. R., Arai, T., Bell, J. M., and Rapoport, S. I. 1996. Preferential in vivo incorporation of [3H]arachidonic acid from blood into rat synaptosomal fractions before and after cholinergic stimulation. J. Neurochem. 67:822-829.
18. Bradford, M. M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-257.
19. 2 in homogenate of sea urchin sperm by delta-9-tetrahydrocannabinol. Biochem. Pharmacol. 42:899-904.
20. 2. Anal. Biochem. 232:7-23.
21. Kim, Y. S., and Padilla, G. M. 1978. Determination of free Ca ion concentrations with an ion-selective electrode in the presence of chealating agents in comparison with calculated values. Anal. Biochem. 89:521-528.
22. Pete, M. J., Wu, D. W., and Exton, J. H. 1996. Subcellular fractions of bovine brain degrade phosphatidylcholine by sequential deacylation of the sn-1 and sn-2 positions. Biochim. Biophys. Acta 1299:325-332.
23. Dawson, E., Parfitt, E., Roberts, Q., Daniels, J., Lim, L., Sham, P., Nöthen, M., Propping, P., Lanczik, M., Maier, W., Reuner, U., Weissenbach, J., Gill, M., Powell, J., McGuffin, P., Owen, M., and Craddock, N. 1995. Linkage studies of bipolar disorder in the region of the Darier's disease gene on chromosome 12q23-24.1. Am. J. Med. (Neuropsychiat. Gen.) 60:94-102.
24. 2 a predisposing factor in affective illness? Biol. Psychiatry 25:945-961.
25. 2. J. Biochem. (Tokyo) 111:54-60.
26. 2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion. Biochem. J. 318:701-709.
27. 2 isoform in vertebrate brain and in expressed in the limbic system. Trans. Am. Soc. Neurosci. 22:620.
28. 2 after transient global forebrain ischemia in the rat. Stroke 27:527-535.
29. Berridge, M. J., Downes, C. P., and Hanley, M. R. 1982. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem. J. 206:587-595.
30. Berridge, M. J., Downes, C. P., and Hanley, M. R. 1989. Neural and developmental actions of lithium: a unifying hypothesis. Cell 59:411-419.
31. Brami, B. A., Leli, U., and Hauser, G. 1991. Influence of lithium on second messenger accumulation in NG 185-15 cells. Biochem. Biophys. Res. Commun. 174:606-612.
32. Nakamura, S., Asaoka, Y., Yoshida, K., Sasaki, Y., and Nishizuka, Y. 1993. Protein kinase C for cell signaling: A possible link between phospholipases. Adv. Second Messenger Phosphoprotein Res. 28:171-178.
33. Nakamura, S., and Nishizuka, Y. 1994. Lipid mediators and protein kinase C activation for the intracellular signaling network. J. Biochem. 115:1029-1034.
34. Exton, J. H., Taylor, S. J., Augert, G., and Bocckino, S. B. 1991. Cell signaling through phospholipid breakdown. Mol. Cell. Biochem. 104:81-86.
35. 2 activity in the brains of rats. Eur. Arch. Psychiatry Clin. Neurosci. 245:179-182.
36. 2 activity in schizophrenic patients: reduction after neuroleptic therapy. Biol. Psychiatry 22:421-426.
37. 2 activity in schizophrenia: a replication study. Biol. Psychiatry 28: 495-501.
38. 2 activity in schizophrenia. Schizophrenia Res. 16:1-6.
39. 2 activity in schizophrenics and other psychiatric patients. Biol Psychiatry 34:641-649.
40. Asaoka, Y., Nakamura, S., Yoshida, K., and Nishizuka, Y. 1992. Protein kinase C, calcium and phospholipid degradation. Trends Biochem. Sci. 17:414-417.
41. Manji, H. K., Etcheberrigaray, R., Chen, G., and Olds, J. L. 1993. Lithium decreases membrane-associated protein kinase C in hippocampus: selectivity for the α isozyme. J. Neurochem. 61:2303-2309.
42. Mork, A., and Geisler, A. 1989. Effects of GTP on hormonestimulated adenylate cyclase activity in cerebral cortex, striatum, and hippocampus from rats treated chronically with lithium. Biol. Psychiat. 26:279-288.
43. Avissar, S., Schreiber, G., Danon, A., and Belmaker, R. H. 1988. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 331:440-442.
44. 2 via GTP-binding proteins: Arachidonic acid and its metabolites as second messengers. Trends Neurosci. 11:117-123.